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Introduction
A dramatic increase has occurred in recent years in the popularity 
of phytochemicals, nutraceuticals and other dietary products to 
support health and wellness. A majority of adults in the US now 
regularly use products, commonly referred to as supplements, 
containing these ingredients in order to maintain wellness or 
treat an illness. In the past, much of the information supporting 
the efficacy of natural products was anecdotal. However, high 
quality, hypothesis-driven studies in animals and humans as well 
as in in vitro systems have greatly contributed to our knowledge 
of the safety and efficacy of these products and an understand-
ing of the underlying mechanisms. As a consequence, an ever 
increasing number of phytochemicals are being recognized not 
only for their abilities to prevent disease states and support well-
ness (chemoprotective properties), but also to effectively treat 
various diseases.1-4
More than 5,000 phytochemicals with diverse structures and 
functions have been identified to date. Each phytochemical has a 
unique structure and has the potential to alter cellular functions 
in a specialized manner without jeopardizing the macromolecular 
conformations, although their modus-operandi can differ in dif-
ferent research models. In the last two decades, our laboratories 
have conducted mechanistic experiments investigating the anti-
cancer,4,5 anti-toxic,6-9 anti-obese,10 anti-diabetic11 and anti-aging 
properties12-14 of a number of phytochemicals and several uniquely 
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Oolong tea has both active catechin components and the abil-
ity to support energy levels by increasing the metabolic rate and 
fat oxidation based on its polyphenol and caffeine contents.26 
Lipolysis and antioxidant activity are additional effects due to its 
unusual combination of catechins and polyphenols.17,18 Oolong 
tea extracts increase plasma antioxidant capacity,27 and inhibit 
DNA  damage.28,29  Some  studies  report  its  ability  to  suppress 
food intake and weight gain.30-32 A water extract of oolong tea 
prevented the obesity and fatty liver induced by a high-fat diet 
in mice. The consumption of oolong tea over a 6-week period 
resulted in significant weight loss in women, thus exemplifying 
the  clinical  efficacy  of  oolong  tea.  Besides  the  reported  ther-
mogenic effect due to caffeine, human studies have shown that 
the consumption of oolong tea can accelerate energy expenditure 
and fat oxidation in humans. The combined effect of the poly-
phenolic component (EGCG) and caffeine has been theorized to 
be due to an inhibitory action on the enzyme catechol-O-methyl 
transferase which inactivates catecholamines.33,34 Overall, various 
tea components are deemed beneficial for the liver28,35 and cardio-
vascular health.36,37
The  third  phytochemical  ingredient  in  STG  is  guarana 
(Paullinia cupana). Guarana is a rich source of caffeine, and it is 
a source of energy in STG. However, it also helps stimulate the 
metabolic rate, and can improve thermogenesis.38 The amount of 
caffeine present in STG is about the same as half a cup of cof-
fee (45 mg). Guarana containing products are popular among 
athletes because of their ergogenic and “fat burning” effects.39-41 
The beneficial effects of guarana may also be due in part to ame-
liorating exercise-associated oxidative stress,42 since acute exercise 
is known to induce a transient increase in reactive oxygen and 
nitrogen species, evident by several reports of increased oxidative 
damage following acute bouts of aerobic and anaerobic exercise.42 
Guarana seed extract exhibits powerful antioxidant activity,39-41 
and in combination with vitamins/minerals improves task per-
formance, as well as attenuates the increased mental fatigue asso-
ciated with extended task performance.20 In addition, guarana 
extract given to mice suppressed hypoglycemia via promotion 
of  glycogen  resolution.  Extracts  of  yerbe  maté  (leaves  of  Ilex 
paraguayenis) and damiana (leaves of Turnera diffusa var. aph-
rodisiaca) along with guarana seed extract have been shown to 
be useful in modulating physiological processes which influence 
gut motility, food intake and energy balance. Guarana extract 
can also prevent ventricular fibrillation.43 These studies demon-
strate the multipronged role played by guarana seed extract in cell 
metabolism.38-41
Besides  quantifiable  antioxidant  activity,26,41,44-48  the  phy-
tochemical components of STG that affect energy metabolism 
and fat partitioning may be helpful adjuncts in a dietary approach 
to wellbeing and body weight control.26,46,47,50 Epidemiological 
studies have projected that global obesity and the overweight 
epidemic will soon outnumber several other diseases combined. 
Moreover, if this epidemic continues at the present rate, diabe-
tes, hypertension and other metabolic disorders that cause mor-
bidity and mortality will take a great toll on human health and 
health-care costs. Since diet management and exercise alone may 
not resolve an issue of this enormous magnitude, conventional 
designed complex mixtures of phytochemicals,9 nutraceuticals9-11 
and  phytochemical/nutraceuticals  mixtures.9-12  The  majority  of 
these studies have been conducted in in vivo models, and the over-
all results have demonstrated that these phytochemicals can either 
act alone or in combination and can modulate important regula-
tory pathways at the cellular and molecular levels. Structurally dif-
ferent and functionally unique toxicants examined in these studies 
have  included  acetaminophen,  alcohols,  amiodarone,  cadmium 
chloride, dimethylnitrosamine, doxorubicin, furosemide, TCDD 
and thioacetamide.7,8
Based on the above considerations, a unique phytochemical 
mixture (STG) was designed to: (1) provide nutritional support, 
(2) stimulate metabolism, (3) suppress appetite and (iv) provide 
antioxidant and anti-inflammatory support. The presence of oxi-
dative stress in obesity is well documented.15 STG is a novel combi-
nation of three well-investigated phyto-extracts (e.g., sage, oolong 
tea and guarana) and two vitamins (thiamine and niacin) in a 
physiologically active, balanced proportion. STG is known to work 
optimally in conjunction with other phytochemical-nutraceutical 
mixtures, such as the Metabolic Nutrition Systems.
Sage (Salvia officinalis L.) leaf extract, one of the ingredients of 
STG, is a widely used herb. Its extracts contain a variety of poly-
phenols, some of which are also found in tea. These polyphenols 
in combination with caffeine promote energy expenditure and fat 
oxidation.10 Sage leaf constituents also possess immunomodula-
tory effects and its polyphenolic components exhibit antioxidant 
properties, including the ability to decrease reactive oxygen species, 
DNA  fragmentation,  lipid  peroxidation  and  inflammation.16,17 
Furthermore, sage extracts increase reduced glutathione (GSH) 
content,17,18 and glutathione-S-transferase activity18 which are indi-
cators of antioxidant and chemoprotective effects.
Another important ingredient of sage is carnosic acid, which 
at low doses reduces body weight gain and the accumulation of 
epididymal fat when rodents are kept on a high fat diet-fed.19 The 
components of sage extracts also have the ability to influence neu-
ronal receptors, which has implications for modulating appetite 
and food intake.20 Sage extract exhibits hepatoprotective effects, 
stimulates the digestive tract and has cardioprotective properties.21 
Sage extract has been used as a stimulant and diuretic. It suppresses 
pancreatic lipase activity and fat (triglyceride) accretion, which aid 
in body weight reduction. It can reduce NFκB, a transcription 
factor presumably involved in obesity.22 Sage also possesses anti-
diabetic and insulin-like activities. All these beneficial properties 
make this plant component a unique nutraceutical supplement.
For centuries, various forms of tea and tea preparations have 
gained appreciable popularity as a beverage worldwide. It is con-
sumed in three basic forms; green tea, black tea and oolong tea 
(Camelia sinensis). Tea leaf extract contains one of the most com-
plex  mixtures  of  phytochemicals  known  to  humans  with  over 
4,000 bioactive components. Wide ranging benefits of consuming 
tea or tea polyphenols have been described in conjunction with 
various pathological conditions including, hypertension, athero-
sclerosis, diabeties, hypercholesterolemia, liver cancer and obesity. 
These effects are attributed to antioxidative,   anti-thrombogenic, 
anti-inflammatory, hypotensive and hypocholesterolemic proper-
ties of tea polyphenols.23-25www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  131
these organs up until 4 months. However, compared to 2 months, 
all these serum markers showed a slightly declining trend at 4 
months. Except BUN and creatinine, animal gender did not play 
a role in influencing these parameters. Based on this scenario, it 
can be safely concluded that, up to 4 months of exposure, STG 
was safe to these three organs and it did not significantly alter 
medications and herbal supplements can be of considerable assis-
tance. Among these two options, herbal supplements remain the 
top choice because of their safety. An additional testimony that 
most herbal supplements carry is that most of them have been 
tried for thousands of years in non-western cultures, and they 
do not pose immense health risks when consumed in balanced 
proportions.
The goal of this study was the assessment of the safety and 
efficacy  of  STG,  a  phytonutrient/vitamin  combination.  The 
specific objectives of the present investigation were to determine 
whether up to four month exposure of various concentrations 
(1X and 7X) of STG to Fisher 344 male and female rats could: 
(1) influence oxidative stress and genomic integrity of the liver, 
heart and kidneys; (2) change histopathology of multiple vital 
target organs (heart, kidneys, liver); (3) influence weight gain/
loss; and (iv) alter serum chemistry profiles (carbohydrate, lipid, 
protein, electrolyte and enzyme profiles). This study employed 
not only a human-equivalent dose (1X) but also a seven-fold 
higher dose (7X) to study serum chemistry and organ histopa-
thology of seven vital target organs. Since the liver is the primary 
site of metabolism and detoxification of most xenobiotics, kidney 
is the principal site of excretion of toxic products and heart is the 
central organ of the cardiovascular system, oxidative stress and 
genomic integrity of these tissues were also analyzed.
Results
Effects of STG on food consumption and body weight. Figures 
1 and 2 shows the impact of STG on these two vital param-
eters. Nothing was observed out of the ordinary during the entire 
study. Compared to females (Fig. 2), male rats on 7X diet showed 
a tendency to loose weight beginning at 9 weeks and the loss in 
body weight was maintained until the end of the study (Fig. 1). 
It is quite likely that animals may have shown a significant loss of 
weight if this study would have continued beyond 4 months.
Effects of STG on organ specific serum parameters. Table 
1 shows the effects of 1X and 7X concentrations of STG on the 
liver, kidneys and heart specific serum parameters. Since the liver 
is the primary site for xenobiotic metabolism, serum alanine ami-
notransferase (ALT) and aspartate aminotransferase (AST) activ-
ities were determined to monitor the liver function. Likewise, 
creatine kinase (CK) and lactate dehydrogenase (LDH) enzyme 
activities served as markers for cardiac function, and levels of 
blood urea nitrogen (BUN) and creatinine reflected functioning 
of the kidneys. Compared to control, ALT, AST and CK activi-
ties were slightly elevated at 2 months which returned to control 
levels at 4 months. LDH activity remained near normal levels at 
both time points.
Two months of STG exposure lowered BUN levels in males, 
and slightly elevated levels in females. This disparity was not 
observed at 4 months. In contrast, both male and female rats 
exhibited slightly elevated levels of creatinine at 2 months and the 
opposite trend at 4 months. Compared to control, overall BUN 
levels were low in both sexes at 4 months. None of the doses of 
STG significantly altered these vital organ-specific serum param-
eters, and indirectly reflected the lack of adverse effects of STG on 
Figure 1. Continuous exposure to various doses of sTG (s, sage leaf 
extract; T, oolong tea extract; G, guarana seed extract) for up to 4 
months did not alter body weight of female rats. Animals in this study 
were divided into three groups: (1) Control; received regular rat chow 
(AIN-76 base diet); (2) 1X sTG diet: received chow premixed with 1X hu-
man equivalent dose of sTG based on a 70 kg human receiving 192 mg 
of sTG per kg body wt; (3) 7X sTG diet: received chow premixed with 
7X human equivalent of sTG. pre-formulated sTG-vitamin mixture (see 
methods for details) in the form of a powder was used in this study.
Figure 2. Continuous exposure to various doses of sTG for up to 4 
months slightly reduced body weight of male rats. however, weight 
reduction was observed only with high dose of 7X sTG just prior to 4 
months and the lower dose did not show any effect at all. see animal 
treatment details in Figure 1.132  Oxidative Medicine and Cellular Longevity  Volume 3 Issue 2
not play a role and both male and females showed a consistent 
dose response. Overall, timing of exposure did not appear to play 
a major role.
Effects of STG on organ specific SOD activity. Figures 6–8 
present effects of STG on SOD activity in various organs. Tissue 
SOD activity is considered a prime component of the intracellu-
lar antioxidant team. The primary role of SOD is to neutralize 
the normally produced tissue burden of superoxide during cel-
lular metabolism/catabolism ultimately forming H2O2. H2O2 is 
then further degraded into water and oxygen by other enzyme 
systems. Although unanticipated, exposure to STG revealed con-
siderable changes in tissue SOD activity. In general, SOD activ-
ity increased as compared to controls in both sexes at both time 
points.  Female  animals  showed  a  slightly  greater  induction  of 
SOD compared to males, and STG produced a modestly greater 
induction of SOD in the liver and heart compared to the kid-
neys. Likewise, duration of exposure exhibited a minimal effect 
on the overall induction of this enzyme. SOD induction by STG 
did show a dose-response effect. Enzyme activity was found to be 
>2-fold by 7x and <2-fold by 1x in the liver and heart. However, 
kidneys responded poorly to STG and the increase was <1.5-fold 
at  both  doses.  Male  rats  showed  a  slightly  greater  response  at   
2 months.
functioning of these organs. None of the animals became ill or 
died during this 4 month exposure to STG.
Tables 2A and B show changes in serum protein, lipid and 
protein  profiles,  and  electrolytes.  Most  parameters  remained 
near control levels. Small fluctuations and variations in values 
occurred based on gender, dose of STG (1X vs. 7X), duration 
of treatment (2 vs. 4 months), and the fact that each value is 
the mean with the SE for three animals. However, no glaring 
changes occurred that would have been indicative of an adverse 
or toxicological event.
Effects of STG on organellar oxidative stress. Figures 3–5 
depict  levels  of  oxidative  stress  in  various  organs  upon  STG 
exposure. Oxidative stress was indirectly quantitated in the three 
organs via measuring a lipid peroxidation byproduct, malondial-
dehyde (MDA). The most remarkable observation was absence of 
an increased stress due to STG, and in contrast, liver and heart 
tissues showed considerably reduced accumulation of  MDA (as 
reflected by of lipid peroxidation). However, kidneys were unre-
sponsive to STG stimuli. This scenario was anticipated based on 
the effects of STG on SOD and GPx activities which serve as 
scavengers of free radicals in the respective tissues. Additionally, 
it was observed that the female livers showed a dose-response at 
both time points but the males did not. In the heart, gender did 
Table 1. effects of up to 4 months of sTG exposure on liver, kidney and heart specific serum markers and lipid profiles  
of Fisher 344 male and female rats
Serum 
  parameters 
(units)
Female (2 Mo) Male (2 Mo) Female (4 Mo) Male (4 Mo)
Con 1x 7x Con 1x 7x Con 1x 7x Con 1x 7x
ALT (IU/L) 46 ± 4 54 ± 5 64 ± 5
75 ± 
10
78 ± 11 59 ± 8 41 ± 3 46 ± 6 46 ± 3 47 ± 5 54 ± 6 57 ± 8
AsT (IU/L) 75 ± 2 96 ± 3 99 ± 10 95 ± 2 104 ± 2 89 ± 3 83 ± 6 79 ± 5 78 ± 6 57 ± 17 72 ± 3 76 ± 4
CK (IU/L) 269 ± 9
589 ± 
60
380 ± 
23
281 
± 4
256 ± 9 395 ± 2
181 ± 
15
203 ± 
35
106 ± 
26
172 ± 
31
121 ± 
11
221 ± 45
LDh (IU/L)
300 ± 
11
245 ± 11 236 ± 42
275 
± 5
266 ± 
12
309 ± 41
141 ± 
14
131 ± 18 98 ± 13
128 ± 
27
121 ± 
22
140 ± 24
BUN (MG/
DL)
18 ± 2 23 ± 2 20 ± 2 24 ± 2 21 ± 2 16 ± 1 16 ± 1 18 ± 1 18 ± 1 18 ± 0.3
18 ± 
0.9
21 ± 0.9
Creatinine 
(MG/DL)
0.47 ± 
0.03
0.63 ± 
0.03
0.57 ± 
0.03
0.43 ± 
0.3
0.50 ± 
0.00
0.50 ± 
0.06
0.47 ± 
0.09
0.34 ± 
0.03
0.34 ± 
0.03
0.60 ± 
0.06
0.40 ± 
0.05
0.27 ± 
0.06
Cholesterol 
(mg/dL)
130.7 ± 
0.90
102.7 ± 
0.90
112.3 ± 
7.53
140.7 
± 0.33
123.7 ± 
1.45
125.3 ± 
2.73
123.0 ± 
2.52
134.0 ± 
5.77
134.7 ± 
2.73
135.0 ± 
10.0
175.7 ± 
12.8
163.0 ± 
7.02
hDL (mg/
dL)
67.30 ± 
0.70
62.80 ± 
2.63
63.30 ± 
5.53
62.67 
± 0.33
68.90 ± 
2.60
68.03 ± 
1.73
45.00 ± 
0.58
48.67 ± 
2.19
50.00 ± 
0.58*
39.67 ± 
3.28
53.67 ± 
0.33*
52.33 ± 
6.94*
Triglycerides 
(mg/dL)
260.0 ± 
3.06
202.3 ± 
5.18*
147.3 ± 
20.1*
360.0 
± 2.08
475.3 ± 
7.69*
257.7 ± 
1.33*
164.7 ± 
26.0
196.3 ± 
24.7*
200.7 ± 
34.8*
518.0 ± 
56.9
658.0 
± 36.0*
649.0 ± 
15.4*
VLDL 
(meq/L)
52.00 ± 
0.58
40.67 ± 
1.33*
29.33 ± 
3.90*
72.00 
± 0.57
95.00 ± 
1.53*
51.67 ± 
0.33*
33.00 ± 
5.13
39.33 ± 
4.80
40.00 ± 
7.00
103.7 ± 
11.3
131.7 ± 
7.13*
129.7 ± 
3.18*
LDL (meq/L)
11.33 ± 
1.62
13.87 ± 
1.83
34.20 ± 
0.83*
06.00 
± 0.42
00.00 ± 
0.00
38.40 ± 
1.30
45.00 ± 
7.77
46.00 ± 
6.08
44.67 ± 
9.90
06.33 ± 
0.65
04.00 
± 0.36*
00.00 ± 
0.00*
LDL/hDL 
Ratio
00.17 ± 
0.03
00.30 ± 
0.06
00.73 ± 
0.07
00.10 
± 0.00
00.00 ± 
0.00
00.73 ± 
0.03
00.97 ± 
0.18
00.93 ± 
0.13
00.93 ± 
0.20
00.13 ± 
0.00
00.07 
± 0.01
00.00 ± 
0.00
Values represent Mean ± se, n = 3; *p ≤ 0.05 Control vs. treated if indicated; human reference ranges- ALT: 12–31 IU/L; AsT: 0–37 IU/L; Creatine phos-
phokinase: 20–184 IU/L; LDh: 89–187 IU/L; BUN: 8–23 MG/DL; Creatinine: 0.5–1.2 MG/DL; Total cholesterol: 140–200; hDL: 35–60; Triglycerides: 10–190; 
VLDL: 5–40; LDL: 62–130; LDL-hDL Ratio: 1–3.55.www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  133
induction level was higher (>2-fold) at 4 months compared to   
2 months, the 7X dose showed a greater response compared to 
1X, and dose-response effect was similar in both genders. In con-
trast, heart showed a reduced response overall. In the heart, GPX 
activity was slightly higher in males compared to females at 2 
months, whereas both genders exhibited a two-fold increase at 4 
months. With respect to the kidney GPx response, both doses and 
both genders showed a very modest increase (<1.5-fold) except in 
Effects of STG on organ specific GPx activity. Figures 9–11 
depict the effects of STG on GPx activity. Ongoing action of 
SOD usually produces H2O2, and this data is consistent with 
the foregoing results on SOD activity (Figs. 6–8). The enzyme 
GPx primarily acts on H2O2 and breaks it down to water and 
oxygen. Interestingly, STG-exposure showed a differential effect 
on this enzyme activity in different target organs. Liver exhibited 
the maximum induction and the kidneys the least. In the liver, 
Table 2. (A) effects of up to 4 months of sTG exposure on serum glucose, bilirubin and protein profiles of Fisher 344 male and female rats
Protein (units)
Female (2 months) Male (2 months) Female (4 months) Male (4 months)
Con 1x 7x Con 1x 7x Con 1x 7x Con 1x 7x
Glucose (mg/
dL)
233 ± 
10.0
237 ± 
4.00
282 ± 
33.00
210 ± 
1.50
245 ± 
4.00
318 ± 
3.80
166 ± 
4.00
167 ± 
10.0
168 ± 
8.00
207 ± 
4.50
203 ± 
9.00
156 ± 
11.00
Tot. protein 
(g/dL)
7.50 ± 
0.0
7.10 ± 
0.10
6.80 ± 
0.20
7.70 ± 
1.00
6.90 ± 
1.00
6.50 ± 
0.06
7.30 ± 
0.17
7.60 ± 
0.21
7.60 ± 
0.17
8.20 ± 
0.06
8.90 ± 
0.06
8.70 ± 
0.20
Albumin (A) 
(g/dL)
3.9 ± 
0.03
3.6 ± 
0.06
3.50 ± 
0.10
3.80 ± 
0.03
3.40 ± 
0.03
3.40 ± 
0.03
3.80 ± 
0.18
4.10 ± 
0.06
4.00 ± 
0.14
3.57 ± 
0.14
4.00 ± 
0.12
3.96 ± 
0.12
Globulin (G) 
(g/dL)
3.60 ± 
0.03
3.40 ± 
0.03
3.30 ± 
0.17
3.87 ± 
1.3
3.40 ± 
0.09
3.06 ± 
0.09
3.46 ± 
0.03
3.50 ± 
0.20
3.60 ± 
0.17
4.63 ± 
0.12
4.90 ± 
0.6
4.77 ± 
0.09
A/G Ratio 1.10 1.06 1.06 1.03 0.97 1.13 1.13 1.20 1.13 0.80 0.83 0.83
Alkaline 
phosphatase 
(Units/L)
183 ± 
3.48
178 ± 
0.88
157 ± 
9.60
184 ± 
1.66
191 ± 
3.40
144 ± 
0.90
140 ± 
10.0
138 ± 
1.30
120 ± 
7.50
119 ± 
3.93
121 ± 
2.30
129 ± 
3.70
C-Reactive 
protein (mg/
dL)
0.070 
± 0.03
0.100 
± 0.0
0.133 ± 
0.03
0.130 ± 
0.03
0.670 ± 
0.03
0.070 ± 
0.03
0.170 ± 
0.06
0.100 ± 
0.0
0.100 ± 
0.06
0.100 
± 0.00
0.160 ± 
0.03
0.060 ± 
0.03
homocysteine 
(µMol/L
17.2 ± 
1.40
15.8 ± 
0.802
15.70 ± 
2.02
20.20 ± 
1.40
19.10 ± 
3.00
17.60 ± 
1.30
15.90 ± 
0.50
14.90 ± 
0.97
13.60 ± 
1.23
16.40 
± 1.70
17.70 ± 
1.18
15.70 ± 
0.48
Bilirubin (mg/
dL)
0.77 ± 
0.03
0.57 ± 
0.03
0.40 ± 
0.06
0.50 ± 
0.00
0.60 ± 
0.00
0.33 ± 
0.03
0.67 ± 
0.08
0.63 ± 
0.06
0.56 ± 
0.12
0.76 ± 
0.09
1.16 ± 
0.14
0.83 ± 
0.09
Values represent mean ± se, n = 3; *p ≤ 0.05 Control vs. treated if indicated; human reference range: Glucose: 70–105; Tot. protein: 6.0–8.0; Albumin: 
3.5–5.2; Globulin: 1.5–3.0; A/G ratio: 1.5–2.5; Alk. phos.: 0–138; C-Reactive protein: 0–3; homocysteine: 0–12; Bilirubin: 0.2–1.0.
Table 2. (B) effects of up to 4 months of sTG exposure on serum electrolyte profiles of Fisher 344 male and female rats
Electrolyte 
(units)
Female (2 Mo) Male (2 Mo) Female (4 Mo) Male (4 Mo)
Con 1x 7x Con 1x 7x Con 1x 7x Con 1x 7x
Calcium 
(mg/dL)
10.87 ± 
0.03
10.24 ± 
0.20
10.57 ± 
0.19
11.37 ± 
0.18
10.53 ± 
0.12
10.37 ± 
0.03
10.03 ± 
0.17
10.27 ± 
0.29
10.33 ± 
0.09
10.30 ± 
0.20
11.07 ± 
0.07
11.23 ± 
0.03
Magnesium 
(mg/dL)
02.03 ± 
0.07
02.63 ± 
0.03
02.50 ± 
0.25
03.07 ± 
0.03
03.10 ± 
0.10
03.00 ± 
0.06
02.47 ± 
0.17
02.40 ± 
0.29
02.13 ± 
0.12
02.47 ± 
0.40
02.13 ± 
0.21
02.13 ± 
0.07
potassium 
(meq/L)
04.13 ± 
0.15
03.87 ± 
0.07
03.94 ± 
0.09
05.07 ± 
0.03
04.30 ± 
0.06
04.97 ± 
0.07
03.97 ± 
0.20
03.60 ± 
0.25
03.63 ± 
0.15
04.13 ± 
0.13
04.56 ± 
0.03
04.63 ± 
0.58
sodium 
(meq/L)
141.7 ± 
0.90
144.0 ± 
0.57
144.3 ± 
0.89
137.0 ± 
0.58
144.0 ± 
0.58
142.0 ± 
0.58
139.7 ± 
0.89
139.3 ± 
0.67
139.7 ± 
0.89
140.3 ± 
0.34
140.7 ± 
0.67
141.3 ± 
0.88
Chloride 
(meq/L)
106.0 ± 
1.53
103.3 ± 
2.19
101.7 ± 
1.20
102.3 ± 
0.67
103.3 ± 
1.20
102.3 ± 
0.67
101.7 ± 
1.33
102.3 ± 
1.20
103.7 ± 
0.33
96.00 ± 
1.15
103.7 ± 
1.33
102.3 ± 
1.20
phosphorus 
(mg/dL)
05.53 ± 
0.12
05.60 ± 
0.77
06.23 ± 
0.12
06.73 ± 
0.08
06.04 ± 
0.22
07.67 ± 
0.07
06.10 ± 
0.46
06.13 ± 
0.52
06.03 ± 
0.40
07.80 ± 
0.91
06.97 ± 
0.15
08.40 ± 
0.61
Uric acid 
(mg/dL)
01.13 ± 
0.12
02.37 ± 
0.29*
03.63 ± 
0.58*
02.83 ± 
0.17
02.83 ± 
0.03
03.80 ± 
0.06*
01.00 ± 
0.11
01.63 ± 
0.30
01.10 ± 
0.20
01.26 ± 
0.20
01.20 ± 
0.05
01.40 ± 
0.23
Values represent mean ± se, n = 3; *p ≤ 0.05 Control vs. treated if indicated; human reference ranges- Calcium: 8.5–10.5; Magnesium: 1.6–2.6; 3.2–5.4; 
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the male rats at 4 months which exhibited a slightly greater than   
1.5-fold increase in activity.
Effects of STG on total glutathione levels in various organs. 
Figures 12–14 show the influence of STG on total tissue glutathi-
one levels. Although STG was able to enhance the level of this anti-
oxidant in all the three organs, the greatest increase was observed 
in the liver (>1.5 fold). Heart and kidney showed minimal and 
nearly identical responses (<1.25 fold). Liver also showed a time 
dependent increase in GSH in response to STG while the other 
two organs did not. In general, gender of the animals did not play 
a role in modulating the effect of STG, and no adverse effect on 
this vital antioxidant was observed. STG exhibited a dose-response 
effect,  and  overall,  glutathione  fluctuations  strongly  correlated 
with changes in antioxidant enzyme activities (Figs. 3–11).
Effects of STG on integrity of the total cellular DNA (genomic 
+ mitochondrial). The impact of STG on the integrity of the total 
cellular DNA in the three tissues is presented in Figures 15–17. 
This assay is well known for its ability to reliably predict the per-
centage of apoptotic cell death from other forms of cell deaths. 
Since genomic stability is dependent upon several factors, it was 
important to verify the effect of STG in these three vital organs. 
STG did not alter the DNA integrity to any extent in the three 
tissues. Quantitative analysis of percent fragmented and percent 
intact DNA based on a sedimentation-dependent centrifugation 
assay revealed the intactness of the DNA in all the three organs. 
The percent fragmentation was insignificant. In liver and kidneys, 
baseline genomic injury was found to be less than control. Heart 
tissues were found to be neutral to STG exposure. Additionally, 
dose of STG, duration of exposure and animal gender did not 
influence the integrity of cellular DNA in the tissues.
Effects of STG on tissue histopathology. Histopathological 
changes in the liver, heart and kidney in response to STG ingestion 
are presented in Figures 18–20. Specific serum chemistry mark-
ers indirectly reflect tissue health. Tissue biochemistry in contrast, 
mirrors a combination of reversible and irreversible biochemical 
changes and histopathology exhibits actual changes at the cellu-
lar and organ level. Three representative sections from each organ 
from three animals were evaluated. Due to the lack of effects of 
1X STG, only the pathology from the high-dose (7X) exposure is 
presented in this manuscript. Each figure shows one control and 
one 7X STG-exposed section from each organ at both time points. 
Both H&E and PAS stained sections were examined, and virtu-
ally no differences were observed in the overall tissue organiza-
tion and architecture. STG-exposed sections appeared practically 
identical to controls. Although this scenario was anticipated based 
on the serum chemistry and tissue biochemistry data, histopa-
thology showed no adverse influence of STG. Examination of 1X 
STG exposed tissues disclosed pathological architecture identical 
to control sections. Overall, tissue morphology from both genders 
and both time points were identical following exposure to STG.
Discussion
Over the past two decades the use of phytochemicals, nutraceu-
ticals and other herbal products have increased damatically in 
part due to their low level of side effects while providing health 
Figure 3. Four months exposure of various doses of sTG (s, sage leaf 
extract; T, oolong tea extract; G, guarana seed extract) reduced hepatic 
oxidative stress (interpreted as % malondialdehyde accumulation 
resulting from lipid peroxidation). sTG profoundly decreased the oxida-
tive stress level in this organ reflecting a combined antioxidative action 
of the components of sTG. A portion of the liver tissue was homog-
enized, centrifuged and an aliquot of supernatant was reacted with 
TBA to determine TBARs. The absorbance of the resulting pink colored 
solution was used to determine MDA concentrations derived from a 
standard curve (prepared using pure MDA; see methods for details). 
Data are expressed as mean ± seM; n = 3 rats per group. The value is sig-
nificantly different from vehicle treated control if indicated (*p ≤ 0.05).
Figure 4. Four months exposure of various doses of sTG reduced car-
diac oxidative stress (interpreted as % malondialdehyde accumulation 
resulting from lipid peroxidation). Oxidative stress in the heart indirectly 
reflects free radical production and its consequence, lipid peroxidation 
resulting in malondialdehyde accumulation. sTG significantly decreased 
MDA accumulation in this tissue reflecting reduced level of oxidative 
stress. Cardiac tissue processing was identical to as described in Figure 
3. Data are expressed as mean ± seM. n = 3 rats per group. The value is 
significantly different from vehicle treated control if indicated  
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in vivo; (2) results derived from experimental animals may not 
accurately reproduce in humans; (3) a wide range of variations 
in human and experimental settings are often inconclusive; (iv) 
extrapolation of animal exposure data does not accurately suggest 
benefits. Expanding research and anecdotal reports of their ben-
efits have convinced the healthcare community and the general 
population that naturally-derived phytochemicals have the abil-
ity to combat diseases including diabetes, HIV, inflammation, 
cancer, obesity and toxicant-induced organ injuries.1-6,19,25,42,50-53 
Among  all  diseases,  the  obesity  epidemic  may  be  the  most 
serious, and has attracted much attention because it has been 
convincingly characterized as one of the root causes of other sec-
ondary diseases such as diabetes, hypertension and cardiovas-
cular diseases. To remedy obesity alone, the healthcare field has 
spent an incredible amount of resources to look for novel con-
ventional medications and surgical procedures although overall 
success has been very disappointing. An alternative approach 
has been to use phytochemicals or dietary supplements with 
anti-obese properties. This approach has shown great promise 
and is widely applied by the general public including healthcare 
professionals.
STG was used in this study keeping in focus its ability to pro-
mote body’s energy expenditure. Of the two doses used, 1X and 
7X, the higher dose showed a modest but significant weight loss 
in male rats at the end of 4 months (Figs. 1 and 2), whereas 
female rats showed no response. Several possible explanations 
may exist for this observation. The differences in metabolism due 
to gender-specific hormone profiles, very short estrus cycle of rats 
(every 4 days), and length of dose exposure of STG which may 
not have been adequate for this species to show a desired effect at 
the human equivalent dose may have played a role. Although it 
is difficult to pin point a single reason for the differences in an in 
vivo model, the phytochemicals in STG are now commonly used 
by reputable laboratories to understand cellular energy-linked 
mechanisms and in clinical settings to translate experimental 
observations to weight loss protocols.
Investigators have shown that consumption of oolong tea in 
combination  with  EGCG  containing  guarana  caused  greater 
energy expenditure and fat oxidation in men.54 Komatsu et al.46 
reported  that  women  who  consumed  oolong  tea  after  meal 
increased energy expenditure by 10% compared to an energy 
expenditure of 4% for green tea drinkers and 0% for water drink-
ers. Oolong tea consumption prior to eating carbohydrate-rich 
foods curb increases in insulin,31 thus reducing some of the fat-
enhancing tendencies of carbohydrate intake, and consumption 
of the same product for weeks opposes obesity.31,52
It has also been suggested that tea and its components may 
influence  glucose  metabolism  and  diabetic  hyperglycemia 
through several mechanisms, such as enhancing insulin sensitiv-
ity, and some human clinical studies have shown improvement 
in glucoregulatory control and endothelial function.55 Oolong 
tea leaf extracts also contain essential vitamins including A, B 
complex and C, and several minerals. STG’s ingredients in the 
presence of vitamins and minerals may have additional boost-
ing effects on the energy expenditure or the antioxidant system. 
Cumulatively, all these effects suggest that oolong tea compo-
nents exert control over select metabolic pathways.55,56
Pin-pointing mechanisms of actions of these naturally occur-
ring agents remains a major challenge because of one or more of 
the following reasons: (1) in vitro results often do not reproduce 
Figure 5. Four months exposure of various doses of sTG did not alter 
kidney oxidative stress (interpreted as % malondialdehyde accumula-
tion resulting from lipid peroxidation). sTG failed to affect this organ, 
indirectly reflecting no alteration in oxidative stress and a relative lack 
of response. Kidney tissue processing was identical to as described in 
Figure 3. Data are expressed as mean ± seM; n = 3 rats per group. The 
value is significantly different from vehicle treated control if indicated 
(*p ≤ 0.05).
Figure 6. Four months continuous exposure of various doses of sTG 
(s, sage leaf extract; T, oolong tea extract; G, guarana seed extract) 
dramatically increased sOD activity in the liver. Low level of oxidative 
stress clearly indicated the potential of sTG to induce this enzyme activ-
ity. A portion of the liver tissue was homogenized, centrifuged and the 
supernatant used for this assay (see methods for details). sOD activity 
is based on a xanthin oxidase-hypoxanthin system and absorbance is 
monitored at 450 nm. purified sOD enzyme was used to plot a standard 
curve. Data are expressed as mean ± seM; n = 3 rats per group. The 
value is significantly different from vehicle treated control if indicated 
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understand intricacies that often do not surface and remain 
unnoticed during experimentation.
The second series of experiments examined specific serum 
markers to ascertain the safety of STG relative to vital target 
organs in the body (Tables 1 and 2). ALT and AST were used 
for the liver, BUN and creatinine were used for the kidneys and 
CK/LDH were used as biomarkers for the heart to determine any 
adverse influence of STG. The results indicated that STG pro-
duced slightly but not significantly elevated ALT, AST and CK 
activities over control values in female rats and similar increases 
only for CK in male rats, at 2 months of treatment.
Other biochemical markers including serum glucose, biliru-
bin, serum lipids and electrolytes as well as C-reactive protein 
and homocysteine (Tables 1 and 2) were found to be near control 
or below control values indicating no injury to the liver, kidneys 
and the heart or other tissues. Previous studies have demonstrated 
the absence of organ toxicity by extracts of guarana41 and sage.18 
Sage has also been shown to have no effect on ALT and AST, 
indicators of hepatotoxicity, in humans.57 These effects of STG 
clearly establish safety and possibly bioavailability to three major 
organs and other tissues in the body.
Another series of experiments determined the influence of 
STG on tissue oxidative stress (Figs. 3–5) and how it modu-
lated antioxidant pathways to minimize stress (Figs. 6–17) in 
all the organs. STG did not exacerbate the stress levels in any 
of these tissues, but rather quantifiably reduced oxidative stress 
in the liver and heart (Figs. 3–4) while kidneys were unaffected   
(Fig. 5). These results agree with previous studies demonstrating 
that sage extracts suppressed lipid peroxidation.16
Radical-mediated lipid peroxidation is the key to membrane 
injury and subsequent MDA release. MDA concentrations deter-
mined in various tissues indirectly reflect the degree of free radi-
cal mediated lipid peroxidation which is a classic indicator for 
cytotoxic pathways. Minimization of this event is conducive to 
cellular survival and normal growth. Furthermore, the fact that 
organ specific serum chemistry markers (Table 1) did not increase 
after STG exposure indirectly reflected either minimal or below 
normal production of free radicals in these tissues. Whether the 
observed effect was a direct interaction of ingredients of STG 
with the free radicals was not investigated. Besides lipid peroxida-
tion, oxidative stress is considered the root cause of most macro-
molecular injury and minimization of such stress is beneficial to 
vital organs. Since most xenobiotics are naturally routed through 
the liver for biotransformation, occasionally it becomes an acci-
dental victim. Overall, serum chemistry profiles corroborated the 
oxidative stress data, demonstrating little change in serum lipid 
and protein profiles in response to STG. Sage extract has been 
shown to decrease plasma LDL cholesterol and total cholesterol 
while increasing HDL in humans57 and rats.58
The next series of experiments assessed the effect of STG on 
various antioxidant elements that play a key role in the cellular 
defense (Figs. 6–14). The results indicated a differential effect in 
the various organs. STG enhanced SOD activity in all the three 
organs (Figs. 6–8), although liver showed the greatest increase 
in  a  dose  response  manner  and  kidneys  exhibited  the  low-
est response. Similarly, all the three organs showed an increase 
adequate daily intake levels in humans; and (v) bioavailability 
issues  are  additional  confounding  factors.  The  bioavailabil-
ity of active components is beginning to be understood, but 
further research is required to determine whether the results 
from animal studies can be extrapolated to human setting. 
Nevertheless,  a  number  of  phytochemicals  have  progressed 
into clinical trials although major knowledge gaps remain to 
be  filled.  Transgenics  and  humanized  experimental  models 
are  additional  instruments  that  are  now  frequently  used  to 
Figure 8. Four months of continuous exposure of various doses of sTG 
showed modest increases in sOD activity under low level of oxidative 
stress in kidneys. Longer exposure showed a greater response com-
pared to two months exposure. Data are expressed as mean ± seM;  
n = 3 rats per group. The value is significantly different from vehicle 
treated control if indicated (*p ≤ 0.05).
Figure 7. Four months of continuous exposure of various doses of 
sTG dramatically increased sOD activity under low level of oxidative 
stress clearly indicating the potential of sTG to induce the activity of 
this enzyme in the heart. Tissue showed a significant response to sTG 
exposure. Data are expressed as mean ± seM; n = 3 rats per group. The 
value is significantly different from vehicle treated control if indicated 
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stress are under the influence of free radicals, induction or inhibi-
tion of antioxidant elements are under strict genetic control. The 
fact that SOD, GPx and glutathione showed dramatic changes 
under the influence of STG suggests that the components of STG 
were bioavailable and accessible to intracellular compartments. 
However, it can not be speculated whether the components of 
STG acted singly or synergistically to exhibit these profound bio-
chemical changes but experiments are in progress in our labo-
ratories to determine such responses. The ability of the various 
in  glutathione  peroxidase  activity  in  response  to  STG  (Figs. 
9–11), with liver producing the highest and the kidneys the low-
est increase. As far as the total glutathione is concerned, again 
liver was the best responder to STG and kidney was the least   
(Figs. 15–17). Male rats responded to STG better than the female 
rats.  These  parameters  mirrored  unanticipated  but  beneficial 
effects of STG on these prime components of the tissue defense. 
These results clearly mirrored the serum chemistry profiles and 
patterns of oxidative stress, and agree with previous reports where 
sage extracts increased glutathione levels.17,18
Numerous studies have shown that the consequences of uncon-
trolled production of free radicals due to malnutrition, stress, 
depletion of cellular antioxidants due to deregulated metabolism, 
and free radical mediated global oxidation of vital macromol-
ecules are prime contributors to diseases. To circumvent these 
issues, investigators have devised ways to artificially maneuver 
cellular  or  organ-level  regulation  of  glutathione,  vitamin  C, 
vitamin E, micronutrient selenium and some of the antioxidant 
enzymes, such as catalase, peroxidase and glutathione peroxidase. 
These efforts have resulted in a number of successful oxidative-
stress related disease fighting strategies coupled with many fail-
ures. Moreover, a universal strategy has not been found.
Over the last two decades, nutrition experts in the field have 
begun to recognize that naturally-derived antioxidants are sig-
nificantly  healthier  and  the  myriad  of  phytochemicals  com-
monly found in fruits, vegetables and edible plants are naturally 
designed with inherent antioxidant and chemoprotective proper-
ties. Furthermore, they rarely exhibit serious side effects and are 
excellent candidates for maintaining the intracellular and extra-
cellular redox environment. This concept has impacted the basic 
approach to healthcare which is reflected in the continued growth 
in the worldwide sales of natural products in recent years.
Phytochemicals often alter cellular functions in a specialized 
manner  without  jeopardizing  macromolecular  conformations. 
Occasionally, the observed effect of a phytochemical may not be 
its direct effect but rather an indirect action of its metabolite(s), 
and many phytochemicals including those in STG have the abil-
ity to modulate biochemical events at the organ, cellular, subcel-
lular and molecular levels.
STG was formulated such that all of its components work 
together and take advantage of some of these biochemical events 
related to free radicals and oxidative stress in various intracel-
lular compartments. For example, polyphenols found in green 
tea enhance antioxidant (glutathione peroxidase, catalase and 
quinone  reductase)  and  phase  II  (glutathione-S-transferase) 
enzyme activities, inhibit chemically induced lipid peroxida-
tion,  inhibit  irradiation-and  TPA-induced  epidermal  orni-
thine  decarboxylase  (ODC)  and  cyclooxygenase  activities.56 
Similar effects have also been reported for sage and guarana 
extracts.24,59,60 Consistent with the above reports, in this study, 
STG was found to be an excellent inducer of all the key players 
of the antioxidant team.
Overall length of STG exposure or gender did not signifi-
cantly influence the normal functioning of the target organs but 
did show major differences among some of the antioxidant com-
ponents. While serum chemistry parameters and the oxidative 
Figure 9. Four months continuous exposure of various doses of sTG 
(s, sage leaf extract; T, oolong tea extract; G, guarana seed extract) 
dramatically increased Gpx activity in the liver. Gpx primarily neutral-
izes intracellular h2O2 and protects cells from oxidative injury. Male 
rats showed a greater response compared females. enzyme activ-
ity exceeded over two fold at 2 and 4 months in male liver. Data are 
expressed as mean ± seM; n = 3 rats per group. The value is significantly 
different from vehicle treated control if indicated (*p ≤ 0.05).
Figure 10. Four months continuous exposure of various doses of 
sTG dramatically increased Gpx activity in the heart. Female rat heart 
showed a slightly lesser response compared male heart. Data are 
expressed as mean ± seM; n = 3 rats per group. The value is significantly 
different from vehicle treated control if indicated (*p ≤ 0.05).138  Oxidative Medicine and Cellular Longevity  Volume 3 Issue 2
dismutase,  catalase,  GST,  glucose-6-phosphate  dehydrogenase 
and  glutathione-disulfide  reductase  activities  in  the  liver.63 
Fisetin,  galangin,  quercetin,  kaempferol  and  genistein  exhibit 
potent  non-competitive  inhibition  of  sulfotransferase  1A1.64 
Various  phytochemicals  are  inducers  of  CYP450-dependent 
drug metabolism, whereas some others are potent inhibitors.65-68 
The impact on the CYP450 system is extremely important from 
a clinical perspective since co-exposure to these entities along 
with selected drugs can significantly influence the therapeutic 
outcome of a drug. Conversely, some drugs may adversely affect 
biochemical pathways normally under the influence of dietary 
phytochemicals, resulting in unwanted effects. Examples include 
the ability of several phytochemicals to interfere with the cell 
cycle regulatory elements (carcinogen bio-activation, angiogene-
sis and inflammation) and cancer signaling pathways.72 All these 
reports strongly suggest abilities of phytochemicals to interact 
with the genome and influence the cell globally.
Since the late 1990s, our laboratory has conducted mecha-
nistic  experiments  investigating  the  anti-toxic,  anti-cancer, 
anti-apoptotic and anti-necrotic properties of grape seed proan-
thocyanidin extract, quercetin, rutin, hesperitin and Momordica 
charantia and Ocimum sanctum extracts in in vivo models and 
has  elucidated  unique  organoprotective  pathways  when  these 
phytochemicals act alone or in combination.5-9 Protection of the 
genomic integrity is one of the most aggressively pursued goal of 
a cell. Flawed genomic machinery invariably leads to deregulated 
metabolism. In order to verify the integrity of the genome in 
all the three vital organs under the influence of STG, total cel-
lular DNA fragmentation assays were performed (Figs. 15–17). 
Results indicate that STG did not cause genomic injury or any 
type of genomic instability. The lack of DNA damage (fragmen-
tation) does not tell us whether the large increases in SOD and 
GPx activities observed in this study in response to STG are due 
to a genetically-driven induction of new enzymes or an increase 
in enzyme activities. Nevertheless, this outcome is generally con-
sidered beneficial for the organism. Furthermore, both oolong 
tea extract28,29 an d  sage  extract 17  have  been  shown  to  inhibit 
DNA damage, supporting the results of this study with STG. 
Oxidative-stress mediated genomic injury and its prevention in 
phytochemical pre-exposed liver, kidneys and heart has already 
been reported.7,8,51
In addition to all these parameters, histopathological diag-
nosis of H&E and PAS-stained organ sections clearly mirrored 
the serum chemistry changes, and strongly correlated with some 
of the biochemical parameters. Gross tissue morphology indi-
rectly reflected untainted metabolic status in all the three organs. 
Representative sections exposed to the 7x dose of STG are shown 
(Figs. 18–20; Tables 1 and 2). Organ sections from control or 
STG-exposed animals resembled each other with unperturbed 
tissue architecture. Multiple sections were thoroughly examined 
to rule the artifactual changes that may have resulted due to tissue 
processing. Uniform stain intensity reflected health of the cells 
and indirectly discerned intactness of the intracellular organelles. 
Nuclear, cytoplasmic and outer boundaries of the hepatocytes 
were intact. A close examination of kidney sections disclosed 
normal features of proximal tubular cells, distal tubular cells 
components of STG to interact with the genome to exhibit such 
an effect can not be ruled out.
Numerous  examples  of  genomic  regulation  by  nutrients 
(nutrigenomics) have been published in recent years. Pycnogenol 
exerts its anticytotoxic property by stimulating glutathione bio-
synthesis.61 Rosemary extract was found to activate an array of 
detoxification  enzymes  including  glutathione-S-transferase, 
and NAD(P)H: quinone reductase in the lung, liver and stom-
ach.62 Cinnamon and coriander seed extracts increase superoxide 
Figure 11. Four months continuous exposure of various doses of sTG 
caused modest increases in Gpx activity in kidneys. Kidney tissues 
were slightly less responsive compared to the liver and heart. Data are 
expressed as mean ± seM; n = 3 rats per group. The value is significantly 
different from vehicle treated control if indicated (*p ≤ 0.05).
Figure 12. Four months continuous exposure of various doses of sTG 
(s, sage leaf extract; T, oolong tea extract; G, guarana seed extract) 
significantly increased total glutathione content in the liver. Although 
sTG exposure showed a characteristic dose-response effect, the overall 
increase remained within 1.25–1.75 fold. Glutathione content increased 
in both genders, at both time points by all the doses of sTG. Data are 
expressed as mean ± seM; n = 3 rats per group. The value is significantly 
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serum chemistry analysis to indirectly monitor the functioning 
of the vital organs. Brain, heart, kidneys, spleen, duodenum, lung 
and liver were collected, sectioned and the tissues were preserved 
in 10% buffered formalin for histopathology. Tissues were pro-
cessed at Charles River Laboratories, MD.
Serum chemistry and tissue biochemistry. Serum chemistry 
(enzyme, lipid, carbohydrate, electrolyte profiles) analyses were 
performed at a State and FDA certified diagnostic laboratory 
approved to perform and report human data. Serum samples 
and glomerular apparatus. Examination of heart sections showed 
normal skeletal muscle fibers, normal intercalated discs and con-
nective tissue, normal nuclei and scattered fibrocytes. None of 
the areas in any of the target organs revealed the presence of any 
inflammatory cells, indicating the absence of any inflammation. 
Apoptotic cells were rarely found in normal or STG-exposed tis-
sues. All these features clearly established the safety of STG. The 
general health of the animals was another indicator which was 
closely monitored during the entire study. Control and STG-
exposed animals did not show any signs of illness.
In conclusion, 4-month exposure of male and female rats to 
STG dramatically enhanced antioxidant power in the absence of 
any genomic injury to the liver, heart and kidneys. Significant 
changes in antioxidant components indirectly disclosed absorp-
tion, biodistribution and bioavailability of STG at least in these 
three organs and liver showed the best response. Although STG 
exposure did not drastically reduce weight gain, it did help main-
tain  healthy  body  weight  coupled  with  a  robust  antioxidant 
capacity of the vital target organs.
Materials and Methods
Animals  and  animal  housing  conditions.  All  experiments 
were conducted within GLP guidelines. Adult male and female 
Fisher-344 rats were obtained from NCI, Frederick, MD, and 
given access to lab chow (Purina) and tap water ad libitum. All 
animals were allowed to acclimate in an environment of con-
trolled temperature (22–25°C), humidity and light/dark cycle in 
the Long Island University animal facility for two weeks prior 
to initiating the study. All cages were examined several times 
everyday. Body weights of the animals were recorded once every 
week to monitor growth. All animal procedures received prior 
approval by the Institutional IACUC and met or exceeded cur-
rent local/state/federal standards.
Animal  treatments.  Animals  in  this  study  were  divided 
into three groups. Group-1: Control; received regular rat chow 
(AIN-76 base diet). Group-2: 1X STG diet: received chow pre-
mixed with 1X human equivalent of STG (Average human con-
sidered as 70 kg; 192 mg of STG per kg). Group-3: 7X STG 
diet,  received  chow  premixed  with  7X  human  equivalent  of 
STG. Pre-formulated STG-vitamin mixture in the form of a 
powder (ThermoPlus) was supplied by AdvoCare Nutritionals 
(Carrolton, TX).
STG exposure was achieved as follows. STG in powdered form 
was supplied to the diet manufacturer. Pre-calculated amounts of 
STG powder (192 mg STG/kg) were mixed with the AIN-76 base 
diet powder in order to achieve an Average Daily Intake of STG 
(equivalent to a 70 kg human). Control and STG-mixed base diet 
powders were re-pelleted in identical form (approximately 1 inch 
pellets) which was provided to the animals ad libitum. Pellets 
were stored at 4–8°C as recommended by the manufacturers of 
the chow and STG system. This diet provided identical calories 
and continuous STG exposure during each feeding throughout 
the experimental period.
Randomly sorted animals (n = 3 per group) were sacrificed 
by decapitation at 0, 2 and 4 months. Blood was collected for 
Figure 13. Four months continuous exposure of various doses of sTG 
increased total glutathione content in the heart, although not remark-
ably. sTG showed a characteristic dose-response effect but the overall 
increase remained below 1.25 fold in both genders at both time points. 
Data are expressed as mean ± seM; n = 3 rats per group. The value is sig-
nificantly different from vehicle treated control if indicated (*p ≤ 0.05).
Figure 14. Four months continuous exposure of various doses of sTG 
increased total glutathione content in kidneys, although not remark-
ably. sTG exposure showed a characteristic dose-response effect but 
the overall increase remained below 1.25-fold in both genders at both 
time points. Data are expressed as mean ± seM; n = 3 rats per group. 
The value is significantly different from vehicle treated control if indi-
cated (*p ≤ 0.05).140  Oxidative Medicine and Cellular Longevity  Volume 3 Issue 2
were collected and kept frozen at -70°C for delivery in liquid 
nitrogen to the diagnostic laboratory (Bio-Medical Laboratories, 
East Brunswick, NJ). Tissue biochemistry (assessment of oxida-
tive stress, DNA fragmentation) were conducted following the 
methods of Ray et al. (2006) and Cayman Chemical enzyme 
assay  kits  were  employed  to  determine  superoxide  dismutase 
(SOD) activity, glutathione peroxidase (GPx) activity and total 
tissue glutathione contents.
Superoxide dismutase assay/SOD activity (cayman chemi-
cal kit# 706002). SOD activity was assessed by measuring the 
dismutation of superoxide radicals generated by xanthine oxi-
dase—hypoxanthine system based on a reaction sequence: 2O2
.- 
+ 2H+ + SOD → H2O2 + O2 and formation of a formazan dye 
from a tetrazolium salt. Purified SOD was used to plot a stan-
dard curve in order to accurately quantify the activity of all three 
types of SOD (Cu/Zn-, Mn- and Fe-SOD). One unit of SOD is 
defined as the amount of enzyme needed to exhibit 50% dismu-
tation of 2O2
.- radical. The SOD stock solutions (0–200 µL) for 
SOD standard activities (0–0.25 U/ml) contained 20 µL of Cu/
Zn-SOD from bovine erythrocytes dissolved in 1.98 ml of 50 
mM Tris-HCl, pH 8.0. Frozen organs (one-half kidney; one-half 
heart, and ca.100 mg liver) were washed with cold HEPES buffer, 
blotted dry on a filter paper and weighed. Tissues were homoge-
nized in a cold glass with a teflon pestle using a pre-chilled buffer   
(20 mM HEPES, 1 mM EGTA, 210 mM mannitol, 70 mM 
sucrose per gram tissue) and centrifuged at 5,000 xg for 10 min 
at 4°C. Sample background was deducted by omitting xanthine 
oxidase. Total SOD levels were calculated based on absorbance 
at 450 nm according to the formula in the kits and expressed as 
units per gram protein derived from units/ml values. All samples 
were assayed in triplicate and expressed as percent control.
Glutathione  peroxidase  activity  (cayman  chemical  kit# 
703102; GPx: EC# 1.11.1.9). Tissues (one-half kidney;   one-half 
heart, and ca. 100 mg liver) were briefly washed with pre-chilled 
phosphate buffer (pH 7.4) and homogenized in cold Tris buffer 
Figure 15. Four months exposure of various doses of sTG (s, sage 
leaf extract; T, oolong tea extract; G, guarana seed extract) slightly 
decreased the liver DNA fragmentation from the baseline levels in both 
genders at 4 months. Fragmentation was quantitated by differential 
centrifugation, sedimentation and reaction with Burton’s reagent. Frag-
mented DNA was calculated based on % low molecular weight DNA in 
the supernatant compared to total DNA (% fragmented in the soup + 
intact DNA in the pellet) in a given sample. Besides the degree of ge-
nomic injury, DNA fragmentation roughly predicts % cells undergoing 
apoptosis. Data are expressed as mean ± seM; n = 3 rats per group. The 
value is significantly different from vehicle treated control if indicated 
(*p ≤ 0.05).
Figure 16. Four months exposure of various doses of sTG showed no 
deleterious effect on integrity of the genomic DNA in the heart. Overall, 
% fragmentation was lower in sTG exposed hearts compared to the 
control. DNA fragmentation was quantitated by differential centrifu-
gation, sedimentation and reaction with Burton’s reagent. Data are 
expressed as mean ± seM; n = 3 rats per group. The value is significantly 
different from vehicle treated control if indicated (*p ≤ 0.05).
Figure 17. Four months exposure of various doses of sTG showed no 
adverse effect on integrity of the genomic DNA in kidneys. Overall, % 
fragmentation was lower in sTG exposed kidneys compared to the con-
trol. DNA fragmentation was quantitated by differential centrifugation, 
sedimentation and reaction with Burton’s reagent. Data are expressed 
as mean ± seM; n = 3 rats per group. The value is significantly different 
from vehicle treated control if indicated (*p ≤ 0.05).www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  141
Figure 18. Brightfield photomicrographs (40X) of h&e-stained representative sections from the largest lobe of the variously treated rat livers. 
photomicrographs show effects of up to 4 months exposure of 7X dose (high dose) of sTG (s, sage leaf extract; T, oolong tea extract; G, guarana seed 
extract) on the liver histopathology. Most cells discerned intact nucleus and confluent intracellular compartment. sTG exposed tissue sections very 
closely resembled control livers. Analysis of several representative sections from both 1X and 7X sTG exposed livers revealed no architectural  
alterations.142  Oxidative Medicine and Cellular Longevity  Volume 3 Issue 2
reagent) to produce a yellow colored 5-thio-2-nitrobenzoic acid 
(TNB) that absorbs at 405 or 414 nm. The rate of TNB produc-
tion is directly proportional to the concentration of glutathione 
in the sample. The measurement of the absorbance of TNB at 
405 or 414 nm provides an accurate estimation of glutathione in 
the sample. Frozen organs (one-half kidney; one-half heart, and 
ca.100 mg liver) were washed with cold 1x phosphate buffered 
saline (PBS), blotted dry on a filter paper and weighed. Ice-cold 
5% (w/v) metaphosphoric acid (20 ml/g tissue) was added and 
the tissues were homogenized using a cold glass with a Teflon 
pestle. Homogenates were centrifuged at 14,000 xg for 15 min 
at 4°C. Supernatants were used to assay total glutathione. Level 
was expressed in units per gram protein. All samples were assayed 
in triplicate. Total glutathione is expressed as %control nmol/
gram liver.
Determination of tissue malondialdehyde (MDA). Levels of 
oxidative stress and its consequence lipid peroxidation was indi-
rectly measured by malondialdehyde (MDA) concentrations in 
tissue homogenates by TBARS (thiobarbituric acid reactive sub-
stances) reaction using the method of Ray et al. This is a spectro-
photometric method designed to detect pink-colored TBA-MDA 
chromogen at 532 nm. MDA was used as the standard. Frozen 
(50 mM TRIS-HCl; 5 mM EDTA, 1 mM DTT, pH 7.5). The 
homogenate was centrifuged at 10,000 xg for 15 min at 4°C, 
and the final supernatant was used for the assay. The GPx assay 
kit indirectly measures GPx activity by a coupled reaction with 
glutathione reductase (GR). Oxidized glutathione (GSSG), pro-
duced upon reduction of an organic hydroperoxide by GPx, and 
is recycled to its reduced state by GR and NADPH [(1) R-O-
O-H + 2GSH → GPx → R-O-H + GSSG + H2O; (2) GSSG 
+  NADPH  →  GR  →  2GSH  +  NADP+].  The  oxidation  of 
NADPH to NADP+ is accompanied by a decrease in absorbance 
at 340 nm. The rate of decrease in the absorbance at 340 nm 
is directly proportional to the GPx activity in the sample. This 
assay measured all of the glutathione-dependent peroxidases in 
tissue homogenates and is expressed as control nmol/min/ml. 
Final data is expressed as percent control.
Total  glutathione  assay  (GSH  +  GSSG;  cayman  chemi-
cal kit# 703002). This assay kit utilizes a carefully optimized 
enzymatic recycling method for the quantification of glutathi-
one. Glutathione reductase (GR) reduces oxidized glutathione 
(GSSG) to reduced glutathione (GSH). GSH is easily oxidized 
to the disulfide dimer GSSG. The sulfhydryl group of GSH 
reacts with DTNB (5,5'-dithiobis-2-nitrobenzoic acid, Ellman’s 
Figure 19 (see previous page). Brightfield photomicrographs (40X) of h&e-stained representative sections from variously treated rat hearts. pho-
tomicrographs show effects of up to 4 months exposure of 7x dose (high dose) of sTG on the cardiac histopathology. Cardiac myocytes displayed 
normal nuclear and myofibrillar features. Most areas remained devoid of any inflammatory cells. Analysis of several representative sections from both 
1X and 7X sTG exposed hearts revealed no architectural alterations.
Figure 20. Brightfield photomicrographs (40X) of h&e-stained representative sections from variously treated rat kidneys. photomicrographs show 
effects of up to 4 months exposure of 7X dose (high dose) of sTG on the kidney histopathology. Most vital kidney structures (glomerulus, proximal and 
distal tubular cells, brush border zones and cortex areas) remained normal after sTG exposure. Analysis of several representative sections from both 
1X and 7X sTG exposed kidneys revealed no architectural alterations.www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  143
intact DNA)]. DNA appearing in the supernatant was divided by 
the total DNA to generate percentage fragmentation. Treatment 
effects were reported as percent control fragmentation.
Histological evaluation. A board certified CRL laboratory vet-
erinarian read all the final H&E/PAS stained slides and provided 
a report (regulatory spirit). Upon receipt of the report, one of us 
(SR) examined all the slides of all the organs and recorded the 
details. Characteristics of apoptosis, necrosis and apocrosis were 
determined based on our previously published procedures.55-58 
Histopathology pictures were taken using a Carl-Zeiss brightfield 
microscope.56
Statistical analysis. Results are presented as mean ± SEM 
unless otherwise indicated. Data were analyzed for significance 
(p  <  0.05)  using  analysis  of  variance  (ANOVA)  followed  by 
Fisher PLSD test (Stat View II, Abacus Concepts Inc., Berkeley, 
California). Differences were attributed to treatment rather than 
chance variance when p < 0.05.
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tissue homogenates (at -70°C prepared in PBS) were treated with 
BHT used to determine levels of oxidative stress. The values are 
expressed as nmol MDA/g liver and presented as percent control 
changes. Triplicate assays were performed in each measurement 
and the average values were obtained from each individual tissue 
sample.73
Analysis  of  genomic  DNA  fragmentation.  DNA  damage 
was quantitated in organ homogenates (n = 4 or more) from 
each treatment group.74-76 To measure DNA fragmentation by 
spectrophotometry, the whole frozen tissues were homogenized 
in chilled lysis buffer (10 mM Tris-HCl, 20 mM EDTA, 0.5% 
Triton X-100, pH 8.0). Homogenates were then centrifuged at 
27,000 xg for 20 min to separate intact chromatin in the pellet 
from fragmented DNA in the supernatant. Pellets were resus-
pended in 0.5 N perchloric acid and supernatants were treated 
with  concentrated  perchloric  acid  to  reach  a  final  concentra-
tion of 0.5 N. All the samples were boiled at 90°C for 15 min 
and centrifuged at 8,000 xg for 10 min to co-precipitate protein 
along with other debris. Resulting supernatants were then treated 
with diphenylamine for 16–20 h at room temperature to develop 
color. DNA standards (59-29-hexose-monophosphate) at various 
concentrations were also prepared and treated with diphenylam-
ine. Absorbances for samples and standard solutions were mea-
sured at l,600 nm with a Beckman DU 640 spectrophotometer. 
A standard concentration vs. absorbance curve was generated and 
sample DNA levels were extrapolated from this standard curve. 
DNA fragmentation in control samples were treated as 100% 
fragmentation based on a formula [(frag. DNA)/(frag. DNA + 
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